Effect of gene polymorphisms on lipoprotein levels in patients with dyslipidemia of metabolic syndrome.

Abstract

Dyslipidemia in the metabolic syndrome (MS) is considered to be one of the most important risk factors for atherosclerosis. It is characterized by hypertriglyceridemia, low concentration of plasma HDL-cholesterol, predominance of small dense LDL particles and an increased concentration of plasma apolipoprotein B (apoB). The pathogenesis of this type of… (More)

Topics

3 Figures and Tables

Cite this paper

@article{Stankov2006EffectOG, title={Effect of gene polymorphisms on lipoprotein levels in patients with dyslipidemia of metabolic syndrome.}, author={Alena Stan{\vc}{\'a}kov{\'a} and L Baldaufov{\'a} and M. Javorsky and Miriam Koz{\'a}rov{\'a} and J{\'a}n {\vS}alagovi{\vc} and Ivan Tk{\'a}{\vc}}, journal={Physiological research}, year={2006}, volume={55 5}, pages={483-90} }